HIGHLIGHTS
- who: Vanessa Desantis and colleagues from the Department of Biomedical Sciences and Human Oncology, Pharmacology Section, University of Bari Aldo have published the article: The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value, in the Journal: (JOURNAL) of 28/04/2022
SUMMARY
2022, 11, 2513. https://doi.org/10.3390/jcm11092513 2 of 20 and one or more of the newer agents-such as proteasome inhibitors (i.e., bortezomib, carfilzomib, and ixazomib), checkpoint inhibitors, immunomodulating compounds (i.e., lenalidomide, thalidomide, and pomalidomide . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.